1Nacht M, Draeheva T, Gao Y, et al. Molecular characteristics af non-small cell lung cancer [ J ] . Pro Nail Acad Sci USA, 2001, 98 ( 26 ) : 15203-15208.
2Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [ J ] . Pro Natl Acad Sci USA, 2001,98:13790-13795.
4Diederichs S, Bulk E, Steffen B, et al. S100 family members and trypsinogens are predictors of distinct metastasis and survival in early- stage non-small cell lung cancer [ J ] . Cancer Res, 2004,64 ( 16 ): 5564-5569.
5Gemma A, Takenaka K, Hosoya Y, et al. Altered expression of several genes in highly metastatic subpopulations of a human puhnonary adenocarcinoma cell line [ J] . Eur J Cancer, 2001, 37 : 1554-1561.
2Zhao J, Kim JE, Reed E, et al. Molecular mechanism of antitumor activity of taxanes in lung cancer. Int J Oncol, 2005,27 (1) : 247- 256.
3Huisman MT, Chhatta AA, van Tellingen O, et al. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer, 2005, 116 (5):824-829.
4Hopper-Borge E, Chen ZS, Shchaveleva I, et al. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10) : resistance to docetaxel. Cancer Res, 2004,64 (14) : 4927-4930.
5Brooks TA, Kennedy DR, Gruol DJ, et al. Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators. Anticancer Res,2004,24(2A) : 409-415.
6Chun E, Lee KY. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun,2004,315(3) :771-779.
7Zhang M, Mukherjee N, Bermudez RS, et al. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Prostate,2005,64(3) : 293-302.
8Cassinelli G, Supino R, Perego P, et al. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes. Int J Cancer,2001,92(5) : 738-747.
9Witters LM, Santala SM, Engle L, et al. Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells. Am J Clin Oncol,2003,26(1) :50-54.
10Sonnemann J, Gekeler V, Ahlbrecht K, et al. Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vineristine and paclitaxel. Cancer Lett, 2004, 209(2) : 177-185.
4Raivich G, Bohatschek M, Kloss CU, et al. Neuroglial activation repertoire in the injured brain : graded response, molecular mechanisms and cues to physiological function [ J ] . Brain Res Rev, 1999, 30 (1):77-105.
5Tomizawa K, He X, Yamanaka H, et al. Injury induces neuropsin mRNA in the central nervous system [ J ]. Brain Res, 1999,824 ( 2 ): 308-311.
6Muessel MJ, Berman NE, Klein RM. Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cortical injury [ J ] . Brain Res, 2000, 870 ( 1-2 ) : 211-221.
7Morrison B 3rd, Eberwine JH, Meaney DF, et al. Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization [ J ] . Neuroscience, 2000, 96 ( 1 ) : 131-139.
8O'Dell DM, Raghupathi R, Crino PB, et al. Traumatic brain injury alters the molecular fingerprint of TUNEL-positive cortical neurons in vivo : A single-cell analysis [ J ] . J Neurosci, 2000, 20 ( 13 ) : 4821-4828.
9Matzilevich DA, Rail JM, Moore AN, et al. High-density microarray analysis of hippocampal gene expression following experimental brain injury [ J ] . J Neurosci Res, 2002, 67 ( 5 ) : 646-663.
10Long Y, Zou L, Liu H, et al. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury[ J ]. J Neurosci Res, 2003, 71 ( 5 ) : 710-720.
